The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...
Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow ...
Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But ...
A WOMAN divided opinions with her plan to confront her mother-in-law for using weight loss injections.  She said her ...
Munjaro and Ozempic have emerged as useful tools for weight loss, particularly for people dealing with obesity or type 2 ...
Weight-loss jabs are not a quick fix for an “Instagram body”, the Health Secretary has warned. The medicines regulator has ...
There were no discontinuations of the drug at the highest dose ... looking to maintain their weight loss, or ...
Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.
Lilly last week reported a rare $1.5 billion sales miss for its injectable obesity drug Zepbound and ... again be in focus when Novo reports results for its diabetes drug Ozempic and ...
The FDA urges healthcare professionals to stop administering the products, and patients should stop using them.